There are approximately 27,000 people with type two diabetes in the greater Waikato and the team’s goal is to build capacity in primary care so that whānau receive the best evidence-based care regardless of the provider they access.
They identified barriers to optimal diabetes care, which included reduced co-ordination and variation in care between practices. Lack of specialist expertise and evidence-based updates were also identified.
Through the support to practices that the team, which comprises a nurse, pharmacist, dietitian and endocrinologist, has provided, the average HbA1c of 47% of people living with type two diabetes in the Waikato is now under 53mmol/mol.
HbA1c is the measure used to measure for and monitor diabetes. Glucose in the blood sticks to the haemoglobin molecules (Hb), and the higher the glucose, the more sticks.
As haemoglobin is broken down and recycled every three months, the HbA1c is an accurate measure of the average blood glucose in a three-month window. The target for most people with diabetes is an HbA1c under 53mmo/mol.
“We had weekly meetings and developed real-time diabetes dashboards in each primary health organisation, so we are all collecting the same data,” said Knight.
“We have facilitated comprehensive common form updates and provided clear and consistent messaging to all practices, and every practice has a copy of the team’s diabetes manual, regardless of who their PHO is.”
They ran basic and advanced diabetes education days, bi-monthly online updates via Zoom, consistent messaging on pharmacy-dispensed medication and established a New Zealand Society for the Study of Diabetes advised diabetes management course through Waikato University.
“We’ve still got a lot of work to do but our aim was to show how our collaborative model of care and strong relationships could address the barriers and improve the lives of our diabetes whānau,” said Knight.
